Long-Term Antimicrobial Non-Susceptibility Trends Among Community-Onset Enterobacterales Urinary Isolates in Southern Saudi Arabia, 2013–2023
6 affiliations
- 1Department of Basic Medical Sciences, College of Medicine,
- 2Department of Microbiology and Clinical Parasitology, College of Medicine,
- 3Department of Pathology, College of Medicine
- 4College of Medicine,
- 5College of Medicine, King Khalid University,
- 6College of Applied Medical Sciences,
Abstract
Nada Abdullah Alharbi,1 Yahya Shabi,2 Khalifa Binkhamis,3 Fawaz Naif M AlQarni,4 Khalid Mofareh A Asiri,5 Ali Dhafer Ali Shehri,5 Abdulrhman Zaher Albarqi,5 Ziyad Saad Saeed,5 Abdullah Zaher Alshehri,5 Mohammed Alhussain Mohammed Al Sadah,6 Ali Alhussein Mohammed Al Sadah,5 Ahmed Aedh A Alshehri,5 Hatem Soliman A Alwaleedi,5 Layan Saleh Alharbi7 1Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 2Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia; 3Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 4Department of Neurology, Aseer Central Hospital, Aseer Cluster, Abha, Saudi Arabia; 5College of Medicine, King Khalid University, Abha, Saudi Arabia; 6Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia; 7College of Applied Medical Sciences, Qassim University, Qassim, Saudi ArabiaCorrespondence: Nada Abdullah Alharbi, Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Airport Road, King Khalid International Airport, Riyadh, 11564, Saudi Arabia, Tel +966 55 597 1596, Email [email protected]: Community-onset urinary tract infections are a major driver of antimicrobial use and resistance, yet long-term regional data on resistance trajectories among Enterobacterales in southern Saudi Arabia are limited. This retrospective repeated cross-sectional study assessed antimicrobial non-susceptibility trends.Patients and Methods: Urine cultures from ambulatory patients aged ≥ 12 years meeting the study definition of community onset collected between 2013 and 2023 were analyzed. Non-duplicate Enterobacterales isolates were included, and historical susceptibility categories were analyzed as recorded, without reinterpretation using later Clinical and Laboratory Standards Institute breakpoints. Temporal trends were evaluated using segmented log-linear regression, reporting annual and average annual percentage changes.Results: A total of 4,825 isolates from 3,611 patients were analyzed. Extended-spectrum cephalosporin resistance (ESC-R), defined as non-susceptibility to at least one evaluated extended-spectrum cephalosporin, accounted for 37.3% of evaluable isolates (1,796/4,816). Overall fluoroquinolone non-susceptibility was 50.4%, with a significant increase after the 2020 breakpoint; prevalence among ESC-R isolates was 77.1%. Nitrofurantoin non-susceptibility increased steadily over time, particularly among Klebsiella pneumoniae, whereas trimethoprim–sulfamethoxazole non-susceptibility declined overall. Concurrent non-susceptibility to all three evaluated oral options was present in 192/4,099 evaluable isolates (4.7%), with no significant overall temporal trend. ESC-R prevalence showed no significant overall temporal trend, with a decline in Escherichia coli and no significant trend in K. pneumoniae. Fosfomycin non-susceptibility was 13.0% among selectively tested isolates; limited testing precluded trend analysis.Conclusion: These single-center findings support local surveillance, culture-guided prescribing, and caution with empiric fluoroquinolone use. Selective testing limits fosfomycin interpretation; further evaluation and standardized testing for appropriate uncomplicated E. coli cystitis are warranted.Graphical Abstract: Three-column infographic about antibiotic resistance trends and related clinical implications. Left column heading reads, Study Overview. An icon shows a specimen container and a magnifying glass over rod-shaped microbes. Text reads, 4,825 Isolates; 2013 to 2023; Southern Saudi Arabia. Middle column heading reads, Rising Resistance Trends. Three rising arrow graphics are labeled with text: Fluoroquinolones plus 1.18 percent per year; Nitrofurantoin plus 3.92 percent per year; TMP to SMX minus 2.36 percent per year. A petri dish icon contains text, ESBL Prevalence tilde 40 percent (persistent). Right column heading reads, Clinical Implications. Four icon and text items read: Fluoroquinolones Not Reliable Empirically; Increasing Nitrofurantoin Resistance; Fosfomycin Most Preserved Oral Option; Culture-Guided Therapy Needed.Infographic on study overview, rising resistance trends and clinical implications for antibiotics.Keywords: enterobacterales, urinary tract infections, antimicrobial non-susceptibility, joinpoint regression, Saudi Arabia
Related
- Comparison of antimicrobial susceptibility testing methods for aztreonam-avibactam against NDM-producing Enterobacterales clinical isolates
- Draft genome sequences and antimicrobial susceptibility profiles of one K1 and five K2 clinical hypervirulent Klebsiella pneumoniae isolates from Ghana
- Application of NaCl-supplemented antimicrobial susceptibility testing conditions to marine bacterial isolates
- Bacterial contamination and antimicrobial susceptibility patterns of isolates from doorhandles at a public university campus in Uganda: A cross-sectional study.
- Methicillin resistance and antimicrobial non-susceptibility trends among Staphylococcus aureus clinical isolates in Aseer, Saudi Arabia (2013–2024): A retrospective laboratory-based surveillance study
BibTeX
@article{alharbi2026longterm,
title = {{Long-Term Antimicrobial Non-Susceptibility Trends Among Community-Onset Enterobacterales Urinary Isolates in Southern Saudi Arabia, 2013–2023}},
author = {Alharbi NA and Shabi Y and Binkhamis K and AlQarni FNM and Asiri KMA and Shehri ADA and Albarqi AZ and Saeed ZS and Alshehri AZ and Al Sadah MAM and Al Sadah AAM and Alshehri AAA and Alwaleedi HSA and Alharbi LS},
journal = {Infection and Drug Resistance},
year = {2026},
month = nov,
url = {https://www.dovepress.com/long-term-antimicrobial-non-susceptibility-trends-among-community-onse-peer-reviewed-fulltext-article-IDR},
note = {CC BY},
}
RIS
TY - JOUR
TI - Long-Term Antimicrobial Non-Susceptibility Trends Among Community-Onset Enterobacterales Urinary Isolates in Southern Saudi Arabia, 2013–2023
AU - Alharbi NA
AU - Shabi Y
AU - Binkhamis K
AU - AlQarni FNM
AU - Asiri KMA
AU - Shehri ADA
AU - Albarqi AZ
AU - Saeed ZS
AU - Alshehri AZ
AU - Al Sadah MAM
AU - Al Sadah AAM
AU - Alshehri AAA
AU - Alwaleedi HSA
AU - Alharbi LS
PY - 2026
DA - 2026/11/15
JO - Infection and Drug Resistance
UR - https://www.dovepress.com/long-term-antimicrobial-non-susceptibility-trends-among-community-onse-peer-reviewed-fulltext-article-IDR
AB - Nada Abdullah Alharbi,1 Yahya Shabi,2 Khalifa Binkhamis,3 Fawaz Naif M AlQarni,4 Khalid Mofareh A Asiri,5 Ali Dhafer Ali Shehri,5 Abdulrhman Zaher Albarqi,5 Ziyad Saad Saeed,5 Abdullah Zaher Alshehri,5 Mohammed Alhussain Mohammed Al Sadah,6 Ali Alhussein Mohammed Al Sadah,5 Ahmed Aedh A Alshehri,5 Hatem Soliman A Alwaleedi,5 Layan Saleh Alharbi7 1Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia; 2Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia; 3Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 4Department of Neurology, Aseer Central Hospital, Aseer Cluster, Abha, Saudi Arabia; 5College of Medicine, King Khalid University, Abha, Saudi Arabia; 6Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia; 7College of Applied Medical Sciences, Qassim University, Qassim, Saudi ArabiaCorrespondence: Nada Abdullah Alharbi, Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Airport Road, King Khalid International Airport, Riyadh, 11564, Saudi Arabia, Tel +966 55 597 1596, Email [email protected]: Community-onset urinary tract infections are a major driver of antimicrobial use and resistance, yet long-term regional data on resistance trajectories among Enterobacterales in southern Saudi Arabia are limited. This retrospective repeated cross-sectional study assessed antimicrobial non-susceptibility trends.Patients and Methods: Urine cultures from ambulatory patients aged ≥ 12 years meeting the study definition of community onset collected between 2013 and 2023 were analyzed. Non-duplicate Enterobacterales isolates were included, and historical susceptibility categories were analyzed as recorded, without reinterpretation using later Clinical and Laboratory Standards Institute breakpoints. Temporal trends were evaluated using segmented log-linear regression, reporting annual and average annual percentage changes.Results: A total of 4,825 isolates from 3,611 patients were analyzed. Extended-spectrum cephalosporin resistance (ESC-R), defined as non-susceptibility to at least one evaluated extended-spectrum cephalosporin, accounted for 37.3% of evaluable isolates (1,796/4,816). Overall fluoroquinolone non-susceptibility was 50.4%, with a significant increase after the 2020 breakpoint; prevalence among ESC-R isolates was 77.1%. Nitrofurantoin non-susceptibility increased steadily over time, particularly among Klebsiella pneumoniae, whereas trimethoprim–sulfamethoxazole non-susceptibility declined overall. Concurrent non-susceptibility to all three evaluated oral options was present in 192/4,099 evaluable isolates (4.7%), with no significant overall temporal trend. ESC-R prevalence showed no significant overall temporal trend, with a decline in Escherichia coli and no significant trend in K. pneumoniae. Fosfomycin non-susceptibility was 13.0% among selectively tested isolates; limited testing precluded trend analysis.Conclusion: These single-center findings support local surveillance, culture-guided prescribing, and caution with empiric fluoroquinolone use. Selective testing limits fosfomycin interpretation; further evaluation and standardized testing for appropriate uncomplicated E. coli cystitis are warranted.Graphical Abstract: Three-column infographic about antibiotic resistance trends and related clinical implications. Left column heading reads, Study Overview. An icon shows a specimen container and a magnifying glass over rod-shaped microbes. Text reads, 4,825 Isolates; 2013 to 2023; Southern Saudi Arabia. Middle column heading reads, Rising Resistance Trends. Three rising arrow graphics are labeled with text: Fluoroquinolones plus 1.18 percent per year; Nitrofurantoin plus 3.92 percent per year; TMP to SMX minus 2.36 percent per year. A petri dish icon contains text, ESBL Prevalence tilde 40 percent (persistent). Right column heading reads, Clinical Implications. Four icon and text items read: Fluoroquinolones Not Reliable Empirically; Increasing Nitrofurantoin Resistance; Fosfomycin Most Preserved Oral Option; Culture-Guided Therapy Needed.Infographic on study overview, rising resistance trends and clinical implications for antibiotics.Keywords: enterobacterales, urinary tract infections, antimicrobial non-susceptibility, joinpoint regression, Saudi Arabia
SN - 1178-6973
ER -